EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MDL ‐800–Induced Sirtuin 6 Activation Decreases Age‐Associated Osteoarthritis in Mice

Matheus Moreira Perez, Pranay Ramteke, Bahiyah Watson, Owen Haslam, Eirene Choi, Susan Chubinskaya, Mandy J Peffers, William R Davis iD, Jacqueline Shine, Brian O Diekman iD, Richard F Loeser iD, Theresa A Freeman und 2 weitere

Arthritis & Rheumatology · 03.11.2026

DOI: 10.1002/art.70342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 03.11.2026. Verfasst von Matheus Moreira Perez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Michael Michelson Gift Fund, NIAMS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Sirtuin 6 (SIRT6) is a nuclear‐localized histone deacetylase that regulates multiple pathways associated with aging. This study aimed to determine whether systemic administration of MDL‐800, a small molecule activator of SIRT6, decreases the severity of age‐associated osteoarthritis (OA) in mice.

Methods

Male, 18‐month‐old mice received weekly intraperitoneal injections of MDL‐800 or vehicle control for 6 months, and OA severity was assessed at 24 months using histology, micro–computed tomography, and histomorphometry. The role of MDL‐800–induced SIRT6 activation in human chondrocyte function was analyzed using RNA sequencing and immunoblotting. The effect of MDL‐800 to reduce DNA damage was assessed in human and mouse synovial fibroblasts by the comet assay.

Results

Mice receiving long‐term administration of MDL‐800 were protected from OA pathology when compared to controls, as characterized by less cartilage damage, osteophyte formation, synovial hyperplasia, subchondral bone sclerosis, and meniscal ossification. RNA sequencing of chondrocytes revealed that MDL‐800 negatively enriched pathways associated with bone formation, angiogenesis, and catabolic MAPK signaling, while positively enriching pathways associated with epigenetic regulation, telomere maintenance, mitochondrial function, redox balance, and DNA repair. MDL‐800 significantly decreased oxidative stress‐induced phosphorylation of p38 in chondrocytes and basal DNA damage in human and mouse synovial fibroblasts.

Conclusion

Activation of SIRT6 by MDL‐800 significantly protected old mice from age‐associated OA severity in vivo. MDL‐800 decreased pathways associated with pathologic bone formation and regulated multiple hallmarks of aging. Targeted therapies that activate SIRT6 may represent a novel strategy to repress multiple aging pathways to slow, stop, or reverse age‐associated OA.

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Department of Pediatrics, Rush University Medical Center, Chicago, Illinois.
  • Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Division of Rheumatology, Allergy and Immunology and the Thurston Arthritis Research Center, University of North Carolina at Chapel Hill.
  • Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina.

ORCID-Profile: William R Davis, Brian O Diekman, Richard F Loeser, John A Collins

Förderung

  • NIA NIH HHS
  • Michael Michelson Gift Fund
  • NIAMS NIH HHS
  • Klaus Kuettner Endowed Chair for Osteoarthritis Research
  • National Institute on Aging
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Perez, M. M., Ramteke, P., Watson, B., Haslam, O., Choi, E., Chubinskaya, S., Peffers, M. J., Davis, W. R., Shine, J., Diekman, B. O., Loeser, R. F., Freeman, T. A., Risbud, M. V., & Collins, J. A. (2026). MDL ‐800–Induced Sirtuin 6 Activation Decreases Age‐Associated Osteoarthritis in Mice. Arthritis & Rheumatology. https://doi.org/10.1002/art.70342

Vancouver

Perez MM, Ramteke P, Watson B, Haslam O, Choi E, Chubinskaya S, et al. MDL ‐800–Induced Sirtuin 6 Activation Decreases Age‐Associated Osteoarthritis in Mice. Arthritis & Rheumatology. 2026. doi:10.1002/art.70342

BibTeX
@article{Perez2026,
  author = {Perez, Matheus Moreira and Ramteke, Pranay and Watson, Bahiyah and Haslam, Owen and Choi, Eirene and Chubinskaya, Susan and Peffers, Mandy J and Davis, William R and Shine, Jacqueline and Diekman, Brian O and Loeser, Richard F and Freeman, Theresa A and Risbud, Makarand V and Collins, John A},
  title = {MDL ‐800–Induced Sirtuin 6 Activation Decreases Age‐Associated Osteoarthritis in Mice},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70342}
}
Kostenlos starten →